A Novel Retinoic Acid-Responsive Element Regulates Retinoic Acid-Induced BLR1 Expression

Molecular and Cellular Biology

Volumn 24, Issue 6, 2004, Pages 2423-2443

  Wang, Jianrong ^a   Yen, Andrew ^a  

^a Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BURKITT LYMPHOMA RECEPTOR 1; CIS ACTING ELEMENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GENE PRODUCT; OCTAMER TRANSCRIPTION FACTOR 1; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOID X RECEPTOR ALPHA; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ARTICLE; BASE PAIRING; BINDING SITE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL STRAIN HL 60; CHROMATIN; DNA FLANKING REGION; DNA FOOTPRINTING; DNA RESPONSIVE ELEMENT; EXON; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RETINOIC ACID RESPONSIVE ELEMENT; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

BASE SEQUENCE; BINDING SITES; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DACTINOMYCIN; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; MODELS, BIOLOGICAL; MUTAGENESIS; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; ORGANIC CATION TRANSPORTER 1; PROMOTER REGIONS (GENETICS); RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; RECEPTORS, RETINOIC ACID; RECOMBINANT PROTEINS; RETINOID X RECEPTORS; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TRETINOIN;

EID: 1542314250     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.6.2423-2443.2004     Document Type: Article

References (62)

1. Altucci, L., A. Rossin, W. Raffelsberger, A. Reitmair, C. Chomienne, and H. Gronemeyer. 2001. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat. Med. 7:680-686.
2. Anderson, K. L., K. A. Smith, K. Conners, S. R. McKercher, R. Maki, and B. E. Torbett. 1998. Myeloid development is selectively disrupted in PU. 1 null mice. Blood 91:3702-3710.
3. Babina, M., K. Mammeri, and B. M. Henz. 2001. Retinoic acid up-regulates myeloid ICAM-3 expression and function in a cell-specific fashion-evidence for retinoid signaling pathways in the mast cell lineage. J. Leukoc. Biol. 69:361-371.
4. Barella, L., M. Loetscher, A. Tobler, M. Baggiolini, and B. Moser. 1995. Sequence variation of a novel heptahelical leucocyte receptor through alternative transcript formation. Biochem. J. 309:773-779.
5. Battle, T. E., and A. Yen. 2002. Ectopic expression of CXCR5/BLR1 accelerates retinoic acid- and vitamin D3-induced monocytic differentiation of U937 cells. Exp. Biol. Med. 227:753-762.
6. Battle, T. E., M. S. Roberson, T. Zhang, S. Varvayanis, and A. Yen. 2001. Retinoic acid-induced blr1 expression requires RARα, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation. Eur. J. Cell Biol. 80:59-67.
7. Battle, T. E., R. A. Levine, and A. Yen. 2000. Retinoic acid-induced blr1 expression promotes ERK2 activation and cell differentiation in HL-60 cells. Exp. Cell Res. 254:287-298.
8. Benoit, G., L. Altucci, M. Flexor, S. Ruchaud, J. Lillehaug, W. Raffelsberger, H. Gronemeyer, and M. Lanotte. 1999. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. EMBO J. 18:7011-7018.
9. Breitman, T. R., S. E. Selonick, and S. J. Collins. 1990. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA 77:2936-2940.
10. Castaigne, S., C. Chomienne, M. T. Daniel, P. Fenaux, R. Berger, and L. Degos. 1990. All-trans retinoic acid as a differentiation therapy in acute promyelocytic leukemia. I. Clinical results. Blood 76:567-572.
11. Chen, L., M. G. Oakley, J. N. M. Glover, J. Jain, P. B. Dervan, P. G. Hogan, A. Rao, and G. L. Verdine. 1995. Only one of the two DNA-bound orientations of AP-1 found in solution cooperates with NFATp. Curr. Biol. 5:882-889.
12. De Luca, L. 1991. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J. 5:2924-2933.
13. Dobner, T., I. Wolf, T. Emrich, and M. Lipp. 1992. Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma. Eur. J. Immunol. 22:2795-2799.
14. Emrich, T., R. Forster, and M. Lipp. 1994. Transmembrane topology of the lymphocyte-specific G protein-coupled receptor BLR1: analysis by flow cytometry and immunocytochemistry. Cell. Mol. Biol. 40:413-419.
15. Forster, R., A. E. Mattis, E. Kremmer, E. Wolf, G. Brem, and M. Lipp. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-1047.
16. Forster, R., I. Wolf, E. Kaiser, and M. Lipp. 1994a. Selective expression of the murine homologue of the G protein-coupled receptor BLR1 in B cell differentiation, B cell neoplasia and defined areas of the cerebellum. Cell. Mol. Biol. 40:381-387.
17. Forster, R., T. Emrich, E. Kremmer, and M. Lipp. 1994b. Expression of the G protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells. Blood 84:830-840.
18. Gaub, M. P., Y. Lutz, E. Ruberte, M. Petkovich, N. Brand, and P. Chambon. 1989. Antibodies specific to the retinoic acid human nuclear receptors α and β. Proc. Natl. Acad. Sci. USA 86:3089-3093.
19. Gianni, M., I. Ponzanelli, L. Mologni, U. Reichert, A. Rambaldi, M. Terao, and E. Garratini. 2000. Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases. Cell Death Differ. 7:447-460.
20. Gonzalez, G. A., K. K. Yamamoto, W. H. Fischer, D. Karr, P. Menzel, W. Biggs, W. W. Vale, and M. R. Montminy. 1989. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature 337:749-752.
21. Gronemeyer, H., and R. Miturski. 2001. Molecular mechanism of retinoid action. Cell. Mol. Biol. Lett. 6:3-52.
22. Gstaiger, M., O. Georgiev, H. Van Leeuwen, P. Van der Vliet, and W. Schaffner. 1996. The B cell coactivator Bobl shows DNA sequence-dependent complex formation with Oct1/Oct-2 factors, leading to differential promoter activation. EMBO J. 15:2781-2790.
23. Gudas, L. J. 1994. Retinoids and vertebrate development. J. Biol. Chem. 269:15399-15402.
24. Gunn, M. D., V. Ngo, K. M. Ansel, E. H. Ekland, J. G. Cyster, and L. T. Williams. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799-803.
25. Hashimoto, Y., M. Petkovich, M. P. Gaub, H. Kagechika, K. Shudo, and P. Chambon. 1989. The retinoic acid receptors α and β are expressed in the human promyelocytic leukemia cell line HL-60. Mol. Endocrinol. 3:1046-1052.
26. Higuchi, T., G. E. Hannigan, D. Malkan, H. Yeger, and B. R. Williams. 1991. Enhancement by retinoic acid and dibutyryl cyclic adenosine 3′:5′-monophosphate of the differentiation and gene expression of human neuroblastoma cells induced by interferon. Cancer Res. 51:3958-3964.
27. Hoeffler, J. P., T. E. Meyer, Y. Yun, J. L. Jameson, and J. F. Habener. 1988. Cyclic AMP-responsive DNA-binding proteins: structure based on cloned placental cDNA. Science 242:1430-1433.
28. Horie, S., H. Ishii, F. Matsumoto, M. Kusano, K. Kizaki, J. Matsuda, and M. Kazama. 2001. Acceleration of thrombomodulin gene transcription by retinoic acid. J. Biol. Chem. 276:2440-2450.
29. Huang, M. E., Y. C. Ye, S. R. Chen, J. R. Chai, J. X. Lu, L. Zhoa, L. J. Gu, Z. Y. Wang. 1988. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567-572.
30. Jozan, S., S. Paute, M. Courtade-Saidi, S. Julie, S. Vidal, R. Bugat, and A. Valette. 2002. All-trans retinoic acid enhances CDDP-induced apoptosis: modulation of the CDDP effect on cell cycle progression. Int. J. Oncol. 20:1289-1295.
31. Kaiser, E., R. Forster, I. Wolf, C. Ebensperger, W. M. Keuhl, and M. Lipp. 1993. The G protein-coupled receptor BLR1 is involved in murine B cell differentiation and is also expressed in neuronal tissues. Eur. J. Immunol. 23:2532-2539.
32. Kastner, P., M. Mark, and P. Chambon. 1995. Nonsteroid nuclear receptors: what are genetic studies telling about their role in real life? Cell 83:859-869.
33. Kato, S., H. Sasaki, M. Suzawa, S. Masushige, L. Tora, P. Chambon, and H. Gronemeyer. 1995. Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Mol. Cell. Biol. 15:5858-5867.
34. Kim, K. Y., K. R. Kweon, M. S. Lee, S. T. Kwak, K. E. Kim, B. D. Hwang, and K. Lim. 1995. Reduced level of octamer binding transcription factor (Oct1) is correlated with H2B histone gene expression during differentiation of HL-60 cells by all-trans retinoic acid. Biochem. Biophy. Res. Commun. 213:616-624.
35. Kliewer, S. A., K. Umesono, D. J. Mangelsdorf, and R. M. Evans. 1992. Retinoic X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signaling. Nature 355:446-449.
36. Kouba, M., M. Vanetti, X. Wang, M. Schafer, and V. Hollt. 1993. Cloning of a novel putative G-protein-coupled receptor (NLR) which is expressed in neuronal and lymphatic tissue. FEBS Lett. 321:173-178.
37. Krust, A., P. Kastner, M. Petkovich, A. Zelent, and P. Chambon. 1989. A third retinoic acid receptor, hRARγ. Proc. Natl. Acad. Sci. USA 86:5310-5314.
38. Legler, D. F., M. Loetscher, R. S. Roos, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1998. B-cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissue, selectively attracts B lymphocytes via BLR1/ CXCR5. J. Exp. Med. 187:655-660.
39. Leid, M., P. Kastner, R. Lyons, H. Nakshatri, M. Saunders, T. Zacharewski, J. Y. Chen, A. Staub, J. M. Garnier, S. Mader, and P. Chambon. 1992. Purification, cloning, and RXR identity of the Hela cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68: 377-395.
40. Lin, B., G. Q. Chen, D. Xiao, S. Kumar Kolluri, X. Cao, H. Su, and X. K. Zhang. 2000. Orphan receptor COUP-TF is required for induction of retinoic acid receptor β, growth inhibition, and apoptosis by retinoic acid in cancer cells. Mol. Cell. Biol. 20:957-970.
41. Lotan, R. 1997. Roles of retinoids and their nuclear receptors in the development and prevention of upper aerodigestive tract cancers. Environ. Health Perspect. 105(Suppl. 4):985-988.
42. Manglesdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-850.
43. Manglesdorf, D. J., U. Kazukiko, and R. M. Evans. 1994. The retinoid receptors, p. 319-349. In M. B. Sporn, A. Roberts, and D. S. Goodman (ed.), The retinoids, 2nd ed. Raven Press, New York, N.Y.
44. McCaffrey, P. G., A. E. Goldfeld, and A. Rao. 1994. The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-α gene transcription. J. Biol. Chem. 269:30445-30450.
45. Montminy, M. R., and L. M. Bilezikjian. 1987. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328: 175-178.
46. Nagpal, S., M. Saunders, P. Kastner, B. Durand, H. Nakshatri, and P. Chambon. 1992. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70:1007-1019.
47. Nagy, L., V. A. Thomazy, G. L. Shipley, L. Fesus, W. Lamph, R. A. Heyman, R. A. Chandraratna, and P. J. Davies. 1995. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 15:3540-3551.
48. Nerlov, C., and T. Graf. 1998. PU. 1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12:2403-2412.
49. Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707-747.
50. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation, and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
51. Veenstra, G. T. C., P. C. Van der Vliet, and O. H. J. Destree. 1997. POU domain transcription factors in embryonic development. Mol. Biol. Rep. 24:139-155.
52. Warrell, R. P., Jr., S. R. Frankel, W. H. Miller, D. A. Scheinberg, L. M. Itri, W. N. Hittelman, R. Vyas, A. Andreff, A. Tafudi, A. Jakubowski, J. Gabrilove, M. Gordon, and E. Dmitrovsky. 1991. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 324:1385-1393.
53. Wingender, E., X. Chen, R. Hehl, H. Karas, I. Liebich, V. Matys, T. Meinhardt, M. Prub, I. Reuter, and F. Schacherer. 2000. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res. 28:316-319.
54. Wolf, I., V. Pevzner, W. Kaiser, G. Bernhardt, E. Claudio, U. Siebenlist, R. Forster, and M. Lipp. 1998. Downstream activation of a TATA-less promoter by Oct-2, Bob1, and NF-κB directs expression of the homing receptor BLR1 to mature B cells. J. Biol. Chem. 273:28831-28836.
55. Yen, A. 1990. HL-60 cells as a model of growth control and differentiation: the significance of variant cells. Hematol. Rev. 4:5-46.
56. Yen, A., L. Placanica, L. S. Bloom, S. Varvayanis. 2001. Polyomavirus small t antigen prevents retinoic acid-induced retinoblastoma protein hypophosphorylation and redirects retinoic acid-induced Go arrest and differentiation to apoptosis. J. Virol. 75:5302-5314.
57. Yen, A., M. Forbes, G. deGala, and J. Fishbaugh. 1987. Control of HL-60 cells differentiation lineage specificity, a late event occurring after precommitment. Cancer Res. 47:129-134.
58. Yen, A., M. S. Roberson, S. Varvayanis, and A. T. Lee. 1998. Retinoic acid induces mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 58:3163-3172.
59. Yen, A., R. Sturgill, and S. Varvayanis. 2000. Retinoic acid increases amount of phosphorylated RAF; ectopic expression of cFMS reveals that retinoic acid-induced differentiation is more strongly dependent on ERK2 signaling than induced Go arrest is. In Vitro Cell. Dev. Biol. 36:249-255.
60. Yen, A., V. Cherington, B. Schaffhausen, K. Marks, and S. Varvayanis. 1999. Transformation defective polyoma middle T antigen mutants defective in PLCγ, PI-3 or SRC kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T. Exp. Cell Res. 248:538-551.
61. Zhang, X. K., B. Hoffman, P. B. V. Tran, G. Graupner, and M. Pfahl. 1992. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355:441-446.
62. Zhang, X. K., and M. Pfahl. 1993. Regulation of retinoid and thyroid hormone action through homodimeric receptors. Trends Endocrinol. Metab. 4:156-162.